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Quality of Life in Patients on Chronic Dialysis: Self-Assessment 
3 Months After the Start of Treatment
Maruschka P. Merkus, MSc, Kitty J. Jager, MD, Friedo W. Dekker, PhD,
Els W. Boeschoten, MD, PhD, Paul Stevens, MD, PhD, Raymond T. Krediet, MD, PhD,
and The Necosad Study Group*
#  The aim of the present multicenter study was to assess quality of life of Dutch dialysis patients 3 months after the 
start of chronic dialysis treatment. The quality of life was compared with the quality of life of a general population 
sample, and the impact of demographic, clinical, renal function, and dialysis characteristics on patients’ quality of life 
was studied. New end-stage renal disease (ESRD) patients who were started on chronic hemodialysis or peritoneal 
dialysis in 13 dialysis centers in The Netherlands were consecutively included. Patients’ self-assessment of quality of 
life was measured by the SF-36, a 36-item Short Form Health Survey Questionnaire encompassing eight dimensions: 
physical functioning, social functioning, role-functioning physical, role-functioning emotional, mental health, vitality, 
bodily pain, and general health perceptions. One hundred twenty hemodialysis and 106 peritoneal dialysis patients 
completed the SF-36. Quality of life of hemodialysis and peritoneal dialysis patients was substantially impaired in 
comparison to the general population sample, particularly with respect to role-functioning physical and general health 
perceptions. Mean role-functioning physical and general health perceptions scores of the hemodialysis patients corre­
sponded with the lowest scoring 8% and 12%, respectively, of the reference group. Mean role-functioning physical 
and general health perceptions scores of the peritoneal dialysis patients corresponded with the lowest scoring 10% 
and 12%, respectively, of the reference group. Hemodialysis patients showed tower levels of quality of life than 
peritoneal dialysis patients on physical functioning, role-functioning emotional, mental health, and pain. However, on 
the multivariate level, we could only demonstrate an impact of dialysis modality on mental health. A higher number 
of comorbid conditions, a lower hemoglobin level, and a lower residual renal function were independently related to 
poorer quality of life. The variability of the SF-36 scores explained by selected demographic, clinical, renal function, 
and dialysis characteristics was highest for physical functioning (29.7%). Explained variability of the other SF-36 
dimensions ranged from 6.9% for general health perceptions to 15.4% for vitality. We conclude that quality of life of 
new ESRD patients is substantially impaired. Comorbid conditions, hemoglobin, and residual renal function could 
explain poor quality of life only to a limited extent. Further research exploring determinants and indices of quality of 
life in ESRD patients is warranted. From a clinical perspective, we may conclude that quality of life should be considered 
in the monitoring of dialysis patients.
© 1997 by the National Kidney Foundation, Inc.
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EALTI-I-RELATED quality of life is a 
multidimensional, patient-centered, dy­
namic concept encompassing physical health and 
symptoms, functional status, mental well-being,
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and social functioning.1 Studies comparing qual­
ity of life between dialysis patients and general 
population samples have not yielded conclusive 
results. Some studies have found quality of life 
of dialysis patients to be inferior to quality of 
life of the general population2'6; others,7'0 how­
ever, have not observed a difference. In addition, 
comparisons of quality of life between hemodial­
ysis and peritoneal dialysis did not indicate one 
of these to be clearly superior.1"'15 These incon­
sistent results may have been caused by small 
sample sizes and the cross-sectional study design 
of these studies. The latter leads to heterogeneous 
treatment groups with respect to the duration of 
therapy and a divergent therapy history. In addi­
tion, insufficient control of background charac­
teristics and the use of different definitions and 
assessment methods of quality of life may have 
attributed to the inconsistent results, Finally, it 
recently became clear that use of recombinant 
human erythropoietin significantly improves 
quality of life.K),t7 Therefore, the results of stud-
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ies conducted before the availability of erythro­
poietin that did not adjust for the level of anemia 
are questionable.
Quality-of-life assessment in reasonable num­
bers of chronic dialysis patients with a multidi­
mensional, reliable, and validated instrument is 
needed. In studies from the United States, the 
United Kingdom, and The Netherlands, the 36- 
item Short Form Health Survey Questionnaire 
(SF-36) has been found to satisfy these require­
ments.!H"21 Moreover, the SF-36 recently has been 
shown to be applicable to dialysis patients,2"5 
However, these latter studies were conducted in 
limited patient groups, and no adjustment was 
made for patient and dialysis characteristics.
The aim of the present multicenter study was 
to assess quality of life, using the SF-36, o f  Dutch 
patients with end-stage renal disease (ESRD) 
who were newly started on chronic dialysis treat-
ment. The quality of life of these patients was 
compared with the quality of life of a general 
population sample, and demographic, clinical, re­
nal function, and dialysis characteristics, associ­
ated with quality of life, were identified.
PATIENTS AND METHODS 
Patients and Procedures
Between October 1, 1993, and April 1, 1995, new ESRD 
patients aged 18 years who were started on chronic hemodi­
alysis or peritoneal dialysis in 13 Dutch dialysis centers were 
consecutively included, These 13 dialysis centers comprise 
27% of the total number of dialysis centers that treat adult 
patients in The Netherlands,
The following major categories of data were analyzed: 
demographic, clinical, renal function, dialysis, and quality of 
life. These data were collected from each subject 3 months 
after the start of chronic dialysis treatment. The choice for 
performing all measurements at 3 months was made because 
the mode of dialysis treatment usually has stabilized by this 
time. Hence, measurements at 3 months are less likely to be 
influenced by metabolic instability than at the initiation of 
treatment.
Demographic, Clinical, Renal Function, and
sis xic (eristics
Demographic variables s tut lied were age, sex, marital sta­
tus, level of education, and employment staLus. Clinical char­
acteristics comprised primary kidney disease, comorbidity» 
use of erythropoietin, hemoglobin, and serum albumin con­
centration, Renal function and dialysis characteristics com­
prised residual renal function, dose of dialysis in terms 
of dialysis-related urea clearance, and protein catabolic 
rate (PCR).
Primary kidney disease was classified according to the
European Dialysis and Transplantation Association-European 
Renal Association registry, “ Renal vascular disease” refers 
to renal vascular disease excluding vasculitis and comprises 
the following subcategories: renal vascular ciisea.se, type un­
specified; renal vascular disease due to malignant hyperten­
sion (no primary renal disease); renal vascular disease due to 
hypertension (no primary renal disease); and renal vascular 
disease, classified. Comorbidity was defined in terms of pres­
ence of nonrenal diseases at the time of commencing renal 
replacement therapy or in the medical history. It was divided 
into three major categories: cardiovascular comorbidity, dia­
betes mellitus, and malignancy. In addition, the total number 
of comorbid conditions was calculated for each patient.
Residual renal Function (residual glomerular IIliration rate 
IrGFR]) was calculated as the mean renal clearance of urea 
and creatinine. The removal of urea by dialysis was expressed 
as the dialysis Kt/VUrtsn. In the hemodialysis patients, dialysis 
Kt/Vlirei, was calculated by the equation of Daugirdas.22 To 
obtain the weekly Kt/Vunjn, this number was multiplied by the 
number of treatments per week, The volume of distribution of 
urea (V) was estimated as 55%  of body weight. This estima­
tion also was used in all other calculations, in the peritoneal 
dialysis patients, dialysis Kt/Vuri>„ was calculated as the perito­
neal Ki7Vurun per 24 hours multiplied by 7. The normalized 
PCR (nPCR) was calculated according to Daugirdas22 in the 
hemodialysis patients. In the peritoneal dialysis patients, it 
was calculated as normalized protein nitrogen appearance 
(nPNA) according to the equation of BergstrOm et al, The 
nPCR and nPNA reflect the protein intake in metabolically 
stable patients. The hemodialysis patients collected ail urine 
during an interdialytic interval. Blood samples were taken 
before and after the dialysis preceding this interval and at the 
end of this interval. The peritoneal dialysis patients collected 
urine and dialysate during a 24-hour period. A blood sample 
was taken during the collection period. Urea and creatinine in 
the plasma, urine, and peritoneal dialysate were determined.
Qua!ity-of-Life Assessment
Patients’ self-assessment of quality of life was measured by 
theMOS SF-36.IH'21 The SF-36 is a generic multidimensional 
instrument consisting of eight multi-item scales representing
(1) physical functioning (extent to which health limits physi­
cal activities, such as self-care, walking, and climbing stairs),
(2) social functioning (extent to which physical health or 
emotional problems interfere with normal social activities),
(3) role-functioning physical (extent to which physical health 
interferes with work or other daily activities), (4) role-fune- 
lioning emotional (extent to which emotional problems inter­
fere with work or other daily activities)» (5) mental health 
(general mental health, including depression, anxiety, belutv- 
ioral-emotional control, and general positive effect), (0) vital­
ity (feeling energetic and full of pep rather than tired and 
worn out), (7) bodily pain (intensity of pain and effect of 
pain on normal work, both inside and outside the home), and 
(8) general health perceptions (personal evaluations of current 
health, health outlook, and resistance to illness). The SF-36 
scores of our ESRD population were compared with the SF- 
36 scores of a general Dutch population sample (n = 1,063; 
age range, 18 to 89 years; 35% male) as described by van 
der Zee et nl.21 SF-36 scores were transformed to a scale of
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Table 1. Dialysis Modality in Relation to Demographic, Clinical, and Dialysis Characteristics
Hemodialysis (n = 120) Peritoneal Dialysis (n -  106)
Demographic
Age (yr), mean ± SD (range)* 59.3 ± 15.5 (18-86) 52.3 ± 14.0 (20-79)
Male 57% 65%
Marriedf 68% 79%
Employed* 16% 38%
Educational status^
Low 64% 52%
Intermediate and high 36% 48%
Clinical
Primary kidney disease
Glomerulonephritis 10% 18%
interstitial nephritis 18% 13%
Cystic kidney disease 13% 10%
Renal vascular, excluding vasculitis 25% 23%
Diabetes mellltus 13% 15%
Other multisystem diseases 8% 9%
Others/unknown 13% 12%
No. of comorbid conditions, mean ± SD (range) 2.2 ± 1,5 (0-8) 1.9 ±  1.4 (0-7)
Type of comorbidity
Cardiovascular 73% 73%
Malignancy* 10% 3%
Diabetes mellitus 16% 19%
Erythropoietin* 83% 67%
Hemoglobin (g/dL),* mean ± SD (range) 9.9 ± 1.4(5.9-14.0) 11.2 ±  1.4 (7.6-14.3)
Serum albumin (g/dL), mean ± SD (range) 3.8 ± 0.5 (27-4.6) 3.7 ±  0.6 (2.2-5.1)
Renal function and dlatysis adequacy, mean ± SD (range)
Residual GFR (mL/min) 3.1 ± 2.6(0.0-14.6) 3.3 ±  2.4 (0.0-10.5)
Dialysis KtA/urea* 27 ± 0.9 (0.6-5.5) 1.5 ±  0.4 (0.6-2.6)
nPCR/nPNA (g/kg/d)* 1.0 ± 0.3 (0.5-1.7) 1.3 ± 0.4 (0.7-2.4)
* P  <  0.05, hemodialysis v peritoneal dialysis, 
t  Patients living together included. 
$ Low: primary schoof, low-level vocational training, low-level secondary school; intermediate and high: high-level 
secondary school, Intermediate and high vocational training, university,
0 to J00, a higher score indicating a belter quality-of-life 
state.
'V.Vi.V
Either /-statistics or chi-square statistics (Fisher's exact 
test, when appropriate) were applied for independent group 
comparisons. Differences between I he mean SF-36 scores of 
the hemodialysis and peritoneal dialysis patients with those 
of the reference population were convened to mean standard 
scores. Standard scores were calculated by dividing the differ­
ence between a given mean SF-36 score of the dialysis group 
and the mean SF-36 score in the reference group by the 
standard deviation of SF-36 scores in the reference group. 
The standard scores indicate how many standard deviations 
the observed SF-36 scores of dialysis patients fall below the 
scores of the reference population (with the scores of the 
reference population set at zero). Univariate relationships be­
tween demographic, clinical, renal function, and dialysis 
characteristics on the one hand, and SF-36 scores on the other 
hand were assessed by Student's /-test, one-way ANOVA,
or Pearson’s correlation coeflicient. As values of dialysis- 
related urea clearance are not equal by technique origin, uni­
variate relations were assessed for each treatment modality 
separately. All .significant characteristics (set at P ^  0.20) 
identified from univariate analysis were studied with multiple 
linear regression (with a stepwise forward selection strategy), 
using the F-stalistics with P 0.05 as the criterion level for 
selection. To search for violations of necessary assumptions 
in multiple regression, normal plots of the residuals of the 
regression models were produced. Furthermore, the inlluence 
of outliers (Cook’s distances) anil possible presence of col lin­
earity (Tolerance/Variance Inflation Factor statistics) were 
assessed. All analyses were made with SAS for Windows 
6.10 (SAS Institute Inc, Cary, NC).
RESULTS
Characteristics o f  Participants and  
Nonparticipants
Two hundred fifty ESRD patients were avail­
able for the study. Of these patients, 226 (90.4%)
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Table 2. Mean (± SD) SF-36 Scores for the General Population Sample and the Hemodialysis
and Peritoneal Dialysis Patients
Group No. PF*t SF* RP* RE*t MH*f VT* BP*| GH*
Hemodialysis 120 50.7 ± 30.8 63.1 ± 29.6 28.6 ± 37.2 52.5 ± 45.4 63.3 ± 20.5 48.9 ± 24.0 63.7 ± 27.3 43,0 20.2
Peritoneal dialysis 106 60.9 ± 24.7 68.9 ± 25.8 31.7 ± 38.3 63.8 ± 39.8 72.2 ± 16.9 51.6 17.9 74.2 t  23.2 46.4 :• 20.5
General population 
sample 1,063 82.0 ± 23.2 86.9 20.5 79.4 ± 35.5 84.1 ± 32.3 76.8 ± 10.4 67A ± 19.9 79.5 ± 25.0 72.7 ± 22.7
Abbreviations: PF, physical functioning; 5F, social functioning; RP, role-funclloning physical; RE, role-functioning emotional; MI-1, mental health; VT, vitality; 
BP, bodily pain; GH, general health perceptions.
* P <  0.05, hemodialysis and peritoneal dialysis patients compared with the roforonce population.
•|- P < 0.05, hemodialysis compared with peritoneal dialysis patients.
completed the SF-36. Twenty-four patients did 
not complete the SF-36 because they did not 
speak the Dutch language sufficiently and/or 
were not able to read and till out the question­
naire by themselves. Except for a lower propor­
tion o f  males and a lower hemoglobin level (P 
<  0.05), nonparticipants were comparable to the 
participants. In the participating hemodialysis pa­
tients, mean age was slightly higher, employment 
rate was lower, prevalence of malignancy was 
higher, dialysis-related Kt/Vuren was higher, and 
nPCR was lower than in the participating perito­
neal dialysis patients (P  <  0,05; Table 1).
Com parison o f  Quality o f  Life Between the 
End-Stage Renal D isease  Patients and a 
G eneral Population Sample
In Table  2, mean SF-36 scores o f  the ESRD 
patients according to treatment modality and 
the general population sample are shown. Both 
hemodialysis and peritoneal dialysis patients 
perceived their quality o f  life as worse than the 
general population sample on all quality-of-life
dim ensions, particu larly  on the ro le-function­
ing physical and general health perceptions di­
mensions. F igure  I show s the differences be­
tween the d ia lysis  patients  and the reference 
group expressed  in s tandard  scores. M ean role- 
functioning physical scores o f  the hem odialysis  
and peritoneal d ia lysis  patients w ere 1.4 and 
1.3 SD below the values o f  the reference group. 
M ean general health  percep tion  scores o f  he­
modialysis and  peritoneal dialysis patients 
w ere 1.3 and L 2  SD below  the values o f  the 
reference group. In o ther  words, mean role- 
functioning physica l scores o f  the hem odia ly ­
sis patients  and the peritoneal dialysis patients 
corresponded to the low est  scoring 8% and 
10% of  the reference  group, respectively. S im i­
larly, mean general health  perceptions scores 
of the hem odia lys is  and peritoneal d ialysis  pa­
tients co rresponded  to the lowest scoring  10% 
and 12% o f  the reference  population, respec­
tively. H em odia lysis  patients dem onstra ted  an 
impaired quali ty  o f  life com pared  with perito­
neal dialysis pa tien ts  w ith  respect to physical
Fig 1. Differences in SF- 
36 scores between the dial­
ysis patients and the refer­
ence group expressed in 
mean standard scores. 
*CentiIes of the reference 
population: for example, X% 
of the reference population 
falls below Xth centile and 
the remaining members fall 
above that point Signifi­
cance values are similar to 
those in Table 2.
0.5
standard scoro contilos*
^  H E  -Q |T  <+, ^  ^  > 11 > » i  t  i  I f  i  ..................... i | i  ^  1 i 11 ■  H  I  X I » t f i l  » I  I W  *  i l  i  h I I I I  ^  1 1  1 > (  1 1 1 , 1  I 1 1 1 s  ' , 0 < *  • s ~ ‘ r -  • -
-0.5
1
-1.5
$
-2
&
&
4P
«
o
•*HD (n®120)
'  !
MPD (n83106) fief,Pop. (n«»1063)
¿S'
■ /  /
f t
ss&
80%
50%
5%
588 MERKUS ET AL
Table 3. Mean SF-36 Scores by Demographic, Clinical, and Dialysis Characteristics
PF SF RP RE MH VT BP GH
Sex
Male 61.0
Female 52.9
Educational level
Low 51.6* 52.7* 64.6* 48.2 43.3
Intermediate/high 61.1 64.9 71.5 52.9 46.4
Employment status
Employed 70.2* 74,4* 38.6* 74.6* 73,6* 55.1* 72.5 49.1*
Unemployed 50,3 62.8 27.0 52.1 65,3 48.4 67,2 43.0
Primary kidney disease
Glomerulonephritis 60.3 68.1* 50.0*
Interstitial nephritis 58,4 59.6 51.3
Cystic kidney 61,1 73.1 54.4
Renal vascular 51.6 59.9 43.1
Diabetes mellitus 44,3 68.8 48,5
Other multisystem 55.8 57.9 50.6
Others/unknown 60.9 77.2 59.7
Diabetes mellitus
Yes 40.8* 39.9
No 58.6 45.6
Cardiovascular comorbidity
Yes 52.8* 27,6 55,4 48.0* 42.6*
No 63.0 36.7 64.4 56.1 50.0
Malignancy
Yes 43.3 54.5 55.7*
No 56.5 66,6 69.5
Erythropoietin
Yes 53.7 43.5
No 61.1 47,9
Dialysis modality
Hemodialysis 50.7* 63.1 52.5* 63.3* 63.7*
Peritoneal dialysis 56,5 68.9 63.8 72,2 74.2
NOTE. Only characteristics significant at the P s  0.20 level are shown. See Table 2 for abbreviations. 
*P  <  0.05.
functioning, ro le-functioning  emotional, m en­
tal health, and bodily pain (Table 2).
A ssocia tions B etw een  D em ograph ic , Clinical, 
Renal Function, an d  D ia lys is  Characteristics  
and Q uality  o f  Life
Univariate associations between SF-36 scores 
and demographic, clinical, renal function, and 
dialysis characteristics are shown in Tables 3 and 
4. Of the demographic characteristics, higher age 
and unemployment were associated with lower 
levels of quality o f  life on most subdimensions. 
None of the SF-36 scores differed between mar­
ried and unmarried patients. With respect to the 
clinical characteristics, a lower hemoglobin and 
an increasing number o f  comorbid conditions
correlated with decreasing quality-of-Iife scores. 
Patients with cardiovascular comorbidity scored 
lower on physical functioning, vitality, and gen­
eral health perceptions than patients without this 
condition. Diabetes mellitus was associated with 
worse physical functioning. Patients with malig­
nant comorbid conditions reported higher levels 
of pain than patients without malignancy. Pa­
tients with renal vascular disease or multisystem 
disease as the primary cause of renal failure re­
ported lower levels of social functioning and vi­
tality than patients with other underlying causes. 
Of parameters of renal function and dialysis ade­
quacy, a lower rGFR correlated with poorer qual­
ity of life on live subdimensions. The nPCR/ 
nPNA only correlated with worse physical func-
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Table 4, Pearson’s Correlation of SF-36 Scores With Demographic, Clinical, and Dialysis Characteristics
NOTE. Only characteristics significant at the P  
* P < 0.05,
4iu''3l 0.20 level are shown. See Table 2 for abbreviations,
PF SF RP RE MH VT BP GH
Total population
Age (yr) -0.44* -0.15* —0.19* -0.22* -0.14* -0.13* -0.12*
No. of comorbid conditions '-0,44* -0.12 -0.17* -0,22* -0.13* -0.1 r -0.21* ■0.23*
Serum albumin 0,21* 0,12
Hemoglobin 0.17* 0.18* 0.12 0.15* 0.18* 0.15* 0.14*
rGFR 0.17* 0.17* 0,22* 0.18* 0.18*
Hemodialysis
Dialysis Kt/Vuren .0,14 — 0,15
nPCR 0.18 0.18 0,14 0.20*
Peritoneal dialysis
Dialysis Kt/VurtK, 0.16
nPNA 0.38* 0.14 0,14 0,19 0,16
lioning in peritoneal dialysis patients and with 
lower vitality in hemodialysis patients. No sig­
nificant univariate associations were observed 
between dialysis Kt/Vuroa and quality-of-life sub­
dimensions.
After introduction of the most important uni­
variate associations (P 0.20) in multivariate 
regression analysis, many of the observed rela­
tionships disappeared (Table 5). However, a 
higher number of comorbid conditions, a lower 
hemoglobin, and a lower rGFR remained associ­
ated with poorer quality-of-lile scores, With re­
spect to dialysis modality, an effect on mental
health persisted in favor of peritoneal dialysis. 
In addition, on the multivariate level, higher age 
and unemployment remained only related to 
lower levels of quality of life on two subdimen­
sions. Primary kidney disease showed only an 
association with lower vitality, attributable to pa­
tients with renal vascular disease. Finally, lower 
nPCR/nPNA levels were associated with worse 
quality of life with respect to physical function­
ing and bodily pain. The selected characteristics 
explained only a small proportion of the variabil­
ity (R~) of the SF-36 scores: 6.9% to 29.7% (Ta­
ble 5).
Table 5. Forward Stepwise Regression Models* to Explain Quality-of-Life Dimensions in Chronic Dialysis
Patients (Standardized Regression Coefficientsf)» Partial Explained Variance (Partial
and Total Explained Variance (Total R2)
sr RP MH VT jM
>lnndurdl/i.Kl rinjreuiîlon
<;onlfl<:kint (pwllul H*)
0.&) (10.0%) 0.13 (4.8%
t;m|iloyjntinl r*tntuu
Prlnmiy kldnoy dliiwmo
No, of c;omorbkl conditions
Humoijlobln
nPOIVnPNA
Huriklunl G PR
Dial y a la moduli I y
0 ,1*1 (8 ,0% )
0 .2(4 (0 .3% )
0.20 (3.ii%)
0.14 (1./%)
0.23 (o.i%)
0.1Ü (G.3%)
0,1 S (2.0%) 
0.13 (1.7%)
0,15 (2.3%)
0.15 (2.8%) 0,1« (2.8%) 0.21 (3.3%)
Total n 20.7% 10.0% 8.4% 13.0%
0.1 B (2.0%) 
0.22 (0.0%)
11.2%
0.1 (» (2.1%) 
0,21 (6 .2%) 
0.15 (2.8%)
0.20 (4.0%)
0,17(3,0%) 0.«« (0.«%) 
0,18 (4,4%)
1i>.4% YA% 0,0%
NOTE, Soo Tnblu 2 for abbreviations.
* No violation« of necessary nsauinptlona In multiple regression analysis could bo detected (examination of roaldunlu, detection of outllors, mouauro» of
collii i m inly),
1 A fit andar dl/od royroBBlori coefficient la computod by dividing q parameter «stimato by the rollo of Ilio sample otnndnrd d ovini Ion al ilio dependent variable 
lo the sample standard deviation of the reareasor.
t- R ' Is the [xtrcMritagu of Iho total variation of iho dependent variable Eicoru (£5^38 dimension) that 1« explained by Iho Independent variables totjotlior, Partial 
Rr‘ la iho port; cm lago variane a In the dipenderti variable eco re that la explained by the single» Independent variable adjusted.
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New ESRD patients" assessment of quality of 
life was observed to be lower than that of a gen­
eral population sample on all distinguished qual- 
ity-of-life dimensions. Because the mean age of 
the reference group (44 years) was lower and 
because SF-36 scores are negatively related with 
age,21 this might have resulted in a slight overes­
timation of the difference 111 quality of life. When 
scores of the ESRD population were compared 
with those of the subgroup of the reference popu­
lation aged 55 to 64 years (n =  140), scores of 
both hemodialysis and peritoneal dialysis pa­
tients were still significantly lower, with the ex­
ception of bodily pain in peritoneal dialysis pa­
tients, In agreement with our finding, some recent 
studies2*5 observed SF-36 scores of ESRD pa­
tients to be lower than scores of a general popu­
lation sample. On the contrary, other investiga­
tors7-9 have reported a comparable quality of life 
for ESRD patients and general population sam­
ples.
Multivariate analysis showed that a higher 
number of comorbid conditions, a lower hemo­
globin level, and a lower residual renal function 
(rGFR) were the most important independent ex­
planatory factors for poorer quality of life. The 
present study is, to our knowledge, the first to 
link residual renal function and amount of dial­
ysis to quality o f  life. The finding that patients 
with a lower rGFR reported a worse quality of 
life, while no effect of dialysis Kt/Vlllca could 
be demonstrated, might suggest that clearance 
achieved by the native kidneys is superior to 
clearance obtained by dialysis. This could be 
caused by the fact that more rGFR will be accom­
panied by bettei* tubular secretion of, for exam­
ple, organic acids and a better preserved hor­
monal function. In addition, deteriorating
residua! renal function may give rise to a worse 
perception o f  quality o f  life by a growing aware­
ness of complete dependence on dialysis, Our 
finding of a negative influence of a higher num­
ber of comorbid conditions and a lower level of 
hemoglobin concentration on quality of life is in 
accordance with former studies.*’10,1(07
Notably, the total explained variation of qual­
ity of life by the selected characteristics was 
small. This suggests that quality of life is deter­
mined by many more factors than the ones we
have assessed in this study. It is reasonable to 
assume that the patients" level of quality of life 
is a result of a complex interaction of disease 
outcome, personal traits, coping behavior, social 
support, and quality of the care received.
Comparison of quality of life between the 
present dialysis groups indicated peritoneal dial­
ysis to be superior only with respect to mental 
health. However, the explained variation by dial­
ysis modality was only 6%. The similarity of 
both dialysis groups with respect to quality of 
life may be due to the foot that all patients had 
just started on dialysis treatment. It can be postu­
lated that in the early phase, perceived quality of 
life is more affected by the dependence on dial­
ysis treatment than by the modality of treatment. 
Comparison o f  our results with previous compar­
isons of quality o f  life between different dialysis 
modalities did not yield a conclusive answer. In 
two large cross-sectional studies, no differences
in perceived quality of life were detected be­
tween hemodialysis and peritoneal dialysis pa­
tients, after adjustment for some demographic 
characteristics, comorbidity status, and duration 
of treatment.8,10 In addition, Tucker et a l14 found 
no difference in perceived quality of life between 
peritoneal dialysis and hemodialysis patients. 
Simmons et al,6 however, observed peritoneal di­
alysis patients to report a more favorable out­
come than hemodialysis patients in terms of 
physical well-being, emotional adjustment, and 
vocational rehabilitation. Additionally, in a com­
parison of quality of life of peritoneal dialysis 
and hemodialysis patients, matched for age, sex, 
race, diabetes, and duration of renal replacement 
therapy (regardless of modality), peritoneal dial­
ysis appeared to be somewhat superior with re­
gard to psychological and social rehabilitation.15 
O11 the other hand, Griffin et a l12 observed that 
hemodialysis patients were not more impaired 
in terms of functional status and showed better 
psychological adjustment compared with perito­
neal dialysis patients. However, hemodialysis pa­
tients had received dialysis treatment for a sig­
nificantly longer period of time than the 
peritoneal dialysis patients (52 months v 29 
months), and therefore may have had more time 
to adjust their lifestyle and emotional reactions.
The inconsistent results in the literature may 
be explained by cross-sectional samples, small 
sample sizes, and improper adjustment for case
QUALITY OF UFE OF CHRONIC DIALYSIS PATIENTS 591
mix. Although some of the described studies ad­
justed for demographic variables, comorbidity, 
and length o f  dialysis therapy, heterogeneity re­
garding prior history o f  renal replacement ther­
apy, like therapy turnover, has been hardly taken 
into account. It may be easily understood that a 
history o f  little or many therapy failures deter­
mines o n e ’s current assessment of quality o f  life.
’eover, application of  different perspectives 
of quality of life assessed with a variety o f  qual- 
ity-of-life instruments can also explain this in­
conclusive picture. This is illustrated by Deniston 
et al, who assessed quality of life o f  a cross- 
sectional sample o f  742 ESRD patients from 
Michigan with 19 different quality-oi-life instru­
ments. Depending on the choice of instrument, 
different conclusions were reached about the re­
lationship between demographic characteristics 
and quality o f  life.
In conclusion, the present findings indicate 
that in new ESRD patients, quality o f  life is sub­
stantially impaired. Comorbidity, hemoglobin 
level, and residual renal function could explain 
variations in quality o f  life only to a limited ex­
tent. Therefore, other potential determinants o f  
quality of life should be explored. In addition, 
health indices other than the SF-36 should be 
examined. Perhaps we should focus more on dis­
ease-targeted indices, such as renal disease and 
dialysis-related problems as perceived by the pa­
tient, Furthermore, longitudinal data are needed 
to obtain insight into the long-term effects o f  
chronic dialysis treatment on patients ' quality o f  
life. W e will elaborate on these issues in our 
future analyses. From a clinical perspective, we 
conclude that quality-of-life assessment should 
be considered in the monitoring of a dialyis pa­
tient as it seems that quality of life cannot be 
extrapolated from conventional clinical charac-
teristies.
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